Is a single dose of ChAdOx1 nCoV‐19 vaccine (AZD1222) enough for people with prior SARS‐CoV‐2 infection or baseline seropositive status?

Detalles Bibliográficos
Autores principales: Deswal, Vikas, Phogat, Rashmi, Sharma, Pooja, Kataria, Sushila, Soin, Arvinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250700/
https://www.ncbi.nlm.nih.gov/pubmed/35793757
http://dx.doi.org/10.1016/j.ijid.2022.06.051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250700/
https://www.ncbi.nlm.nih.gov/pubmed/35793757
http://dx.doi.org/10.1016/j.ijid.2022.06.051

Ejemplares similares